megstamum said
This is a brand new treatment for arthritis which has just been licensed in the UK and EU and is showing extremely positive results in some dogs. It’s called Librela and I understand that a version for cats is shortly coming out too. It’s a monthly injection which inhibits the inflammatory process in the joints. Meg will be starting treatment shortly and I will report how we get on. 

More info here: https://todaysv.....-approval/

and also a video showing how it works

https://players.....r7LdduYCk0

  

It's here! The new monoclonal antibodies arthritis treatment for cats is called Solensia here in the States. Just heard about it this week. Here's a link to the Zoetis Petcare Solensia website for more info.

The medication insert states that:

A 112-day, masked, randomized, controlled field study was conducted at 21 U.S. veterinary clinics.

The study enrolled 275 client-owned cats with clinical signs of osteoarthritis (OA) confirmed by radiography and orthopedic examination; enrolled cats weighed 2.5 to 11.4 kg and were 1.6 to 22.4 years old. The enrolled cats were randomized to treatment with SOLENSIA (n=182) or vehicle control (n=93), administered subcutaneously on Days 0, 28, and 56.

Cats were dosed with SOLENSIA (frunevetmab injection) or vehicle control based on body weight (2.5-7 kg cats received 1 mL, 7.1-14 kg cats received 2 mL).

The primary outcome measure for success for the control of pain associated with OA was comparison of the owner’s evaluation of CSOM at Day 56 compared to baseline (Day 0, before treatment). Treatment success was defined as a reduction of at least 2 in the total CSOM score at Day 56 compared with the score at baseline.

Cats that had an increase in any individual CSOM activity score (regardless of the total CSOM score) or that received rescue analgesia prior to Day 56 were considered treatment failures. Secondary outcome measures included the total CSOM score on Days 28 and 84; Owner Global Assessments on Days 28, 56, and 84; and total orthopedic pain score completed by the veterinarian on Days 28, 56, and 84. For the Owner Global Assessment, success was defined as an owner’s impression of the response to treatment as Good or Excellent (versus Fair or Poor). Success was not defined for the veterinary-assessed total orthopedic pain score. The proportion of cats considered treatment successes based on the owner

CSOM assessment and the Owner Global Assessment was greater in the SOLENSIA group compared to the control group for all assessments. The mean total orthopedic pain score was lower in the SOLENSIA group compared to the control group at all post-dosing assessments.

Twenty four of the Solensia cats had vomiting as a side effect, the most common. Others are listed on the insert. I think I would feel good about giving this to my own cat if I had one.

This new medication is a huge victory for feline pain control!